146 related articles for article (PubMed ID: 19403921)
1. Kappa opioid receptor screen with the Tango beta-arrestin recruitment technology and characterization of hits with second-messenger assays.
Doucette C; Vedvik K; Koepnick E; Bergsma A; Thomson B; Turek-Etienne TC
J Biomol Screen; 2009 Apr; 14(4):381-94. PubMed ID: 19403921
[TBL] [Abstract][Full Text] [Related]
2. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1.
van der Lee MM; Blomenröhr M; van der Doelen AA; Wat JW; Smits N; Hanson BJ; van Koppen CJ; Zaman GJ
J Biomol Screen; 2009 Aug; 14(7):811-23. PubMed ID: 19520790
[TBL] [Abstract][Full Text] [Related]
4. Beta-arrestin-based Bret2 screening assay for the "non"-beta-arrestin binding CB1 receptor.
Vrecl M; Nørregaard PK; Almholt DL; Elster L; Pogacnik A; Heding A
J Biomol Screen; 2009 Apr; 14(4):371-80. PubMed ID: 19403920
[TBL] [Abstract][Full Text] [Related]
5. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors.
Southern C; Cook JM; Neetoo-Isseljee Z; Taylor DL; Kettleborough CA; Merritt A; Bassoni DL; Raab WJ; Quinn E; Wehrman TS; Davenport AP; Brown AJ; Green A; Wigglesworth MJ; Rees S
J Biomol Screen; 2013 Jun; 18(5):599-609. PubMed ID: 23396314
[TBL] [Abstract][Full Text] [Related]
6. A homogeneous fluorescent live-cell assay for measuring 7-transmembrane receptor activity and agonist functional selectivity through beta-arrestin recruitment.
Hanson BJ; Wetter J; Bercher MR; Kopp L; Fuerstenau-Sharp M; Vedvik KL; Zielinski T; Doucette C; Whitney PJ; Revankar C
J Biomol Screen; 2009 Aug; 14(7):798-810. PubMed ID: 19531663
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput screening system for G-protein-coupled receptors using β-lactamase enzyme complementation technology.
ZHAO CK; YIN Q; LI SY
Acta Pharmacol Sin; 2010 Dec; 31(12):1618-24. PubMed ID: 21102483
[TBL] [Abstract][Full Text] [Related]
8. Monitoring β-arrestin recruitment via β-lactamase enzyme fragment complementation: purification of peptide E as a low-affinity ligand for mammalian bombesin receptors.
Ikeda Y; Kumagai H; Okazaki H; Fujishiro M; Motozawa Y; Nomura S; Takeda N; Toko H; Takimoto E; Akazawa H; Morita H; Suzuki J; Yamazaki T; Komuro I; Yanagisawa M
PLoS One; 2015; 10(6):e0127445. PubMed ID: 26030739
[TBL] [Abstract][Full Text] [Related]
9. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.
Wetter JA; Revankar C; Hanson BJ
J Biomol Screen; 2009 Oct; 14(9):1134-41. PubMed ID: 19726785
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed assays by high-content imaging for assessment of GPCR activity.
Ross DA; Lee S; Reiser V; Xue J; Alves K; Vaidya S; Kreamer A; Mull R; Hudak E; Hare T; Detmers PA; Lingham R; Ferrer M; Strulovici B; Santini F
J Biomol Screen; 2008 Jul; 13(6):449-55. PubMed ID: 18519922
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening using beta-lactamase reporter-gene technology for identification of low-molecular-weight antagonists of the human gonadotropin releasing hormone receptor.
Oosterom J; van Doornmalen EJ; Lobregt S; Blomenröhr M; Zaman GJ
Assay Drug Dev Technol; 2005 Apr; 3(2):143-54. PubMed ID: 15871689
[TBL] [Abstract][Full Text] [Related]
12. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
14. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
[TBL] [Abstract][Full Text] [Related]
15. A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors.
Zhao X; Jones A; Olson KR; Peng K; Wehrman T; Park A; Mallari R; Nebalasca D; Young SW; Xiao SH
J Biomol Screen; 2008 Sep; 13(8):737-47. PubMed ID: 18660457
[TBL] [Abstract][Full Text] [Related]
16. Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.
Xu H; McElvain M; Fiorino M; Henkle B; Sherman L; Xu Y; Tominey E; Kelley K; Adlam M; Bürli R; Siu J; Wong M; Cee VJ
J Biomol Screen; 2013 Oct; 18(9):997-1007. PubMed ID: 23686102
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
[TBL] [Abstract][Full Text] [Related]
18. Measurement of β-Arrestin Recruitment at GPCRs Using the Tango Assay.
Laroche G; Giguère PM
Methods Mol Biol; 2019; 1947():257-267. PubMed ID: 30969421
[TBL] [Abstract][Full Text] [Related]
19. G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors.
Verkaar F; van Rosmalen JW; Blomenröhr M; van Koppen CJ; Blankesteijn WM; Smits JF; Zaman GJ
Biotechnol Annu Rev; 2008; 14():253-74. PubMed ID: 18606367
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
